Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome.
Eva Maria WendelHelen Sophie ThonkeAnnikki BertoliniMatthias BaumannAstrid BlaschekAndreas MerkenschlagerMichael KarenfortBarbara KornekChristian LechnerDaniela PohlMartin PritschKathrin SchandaMareike SchimmelCharlotte ThielsStephan WaltzGert WiegandBanu AnlarNina BarisicChristian BlankMarkus BreuPhilip J BroserAdela Della MarinaKatharina DiepoldMatthias EckenweilerAstrid EisenkölblMichael FreilingerUrsula Gruber-SedlmayrAnnette HackenbergTobias IffEllen KnierimJohannes KochGeorg KutschkeSteffen LeizGrischa LischetzkiMargherita NosadiniAlexander PschibulEdith Reiter-FinkDoris RohrbachMichela SalandinStefano SartoriJan-Ulrich SchlumpJohannes StoffelsJurgis StrautmanisDaniel TibussekVictoria TünglerNorbert UtzigMarkus ReindlKevin Rostásynull nullPublished in: Neurology(R) neuroimmunology & neuroinflammation (2022)
In this study, patients with declining MOG-IgG titers, particularly those with seroconversion to MOG-IgG-negative, are shown to have a significantly reduced relapse risk.
Keyphrases